Clofazimine Market Overview
The Clofazimine Market was valued at USD 300 million in 2024 and is projected to reach USD 500 million by 2035, growing at a CAGR of 5.9%. Clofazimine is a riminophenazine antibiotic primarily used for leprosy treatment and increasingly for multidrug-resistant tuberculosis (MDR-TB). The market encompasses three main formulations: capsules, injectables, and topical applications, with capsules...
0 Commentaires 0 Parts 67 Vue 0 Aperçu